IVF With Adenomyosis: Success Rates, Treatment Options and When Surrogacy May Be the Best Path

Having adenomyosis does not prevent you from having a biological child, even if structural uterine changes or repeated implantation failures make carrying a pregnancy difficult.

Many prospective parents facing uterine tissue inflammation create healthy embryos through IVF and successfully transition to gestational surrogacy to protect their investment and achieve parenthood.

Our specialists provide dedicated matching, thorough pre-screening, and financial safeguards to ensure your path to parenthood remains clear and secure.

You can request free surrogacy information today to learn how agency matching and financial protections support your family-building journey.

How Does Adenomyosis Affect IVF?

Adenomyosis occurs when endometrial tissue that normally lines the inside of the uterus grows into the muscular uterine wall, causing chronic inflammation and structural enlargement.

These localized changes alter normal pelvic signaling, disrupt uterine muscle contractions, and impair blood flow throughout the tissue layers.

The biological mechanisms through which adenomyosis impacts conception and embryo implantation include:

Structural Myometrial Distortion: Tissue thickening and junctional zone expansion alter the physical structure of the uterine cavity, hindering embryo attachment.
Altered Uterine Blood Flow: Abnormal vascularization within the affected muscle wall restricts steady blood supply to the developing endometrial lining.
Chronic Local Inflammation: Elevated levels of inflammatory cytokines and altered immune cell activity within the uterine cavity disrupt early embryonic signaling.
Impaired Gene Expression: Reduced expression of critical endometrial receptivity markers, such as HOXA10, weakens the uterine lining's ability to support implantation.
Abnormal Contractility: Irregular muscular contractions in the myometrium can physically disturb an embryo before it implants securely.

Prospective parents can review guidelines on reproductive health to examine how structural uterine conditions are managed during fertility cycles.

IVF Protocol Variations for Patients With Adenomyosis

Reproductive endocrinologists frequently modify IVF protocols to suppress active hormonal stimulation and quiet uterine inflammation prior to an embryo transfer.

Adjusting medication schedules helps manage tissue sensitivity and prepares the uterine environment for potential implantation.

Freeze-All Cycles: Freezing embryos after retrieval allows hormonal stimulation levels to normalize, avoiding fresh transfers into an inflamed environment.
Long GnRH Down-Regulation Protocol: Administering GnRH agonists for one to three months before transfer suppresses estrogen production to shrink adenomyotic tissue.
Modified Antagonist Protocols: Flexible antagonist cycles help manage follicular development during stimulation while avoiding excessive hormone elevation.

Intended parents can examine frozen embryo transfer success statistics to evaluate how frozen protocols optimize clinical conditions.

Surgical Treatment for Adenomyosis Before IVF

Surgical intervention for adenomyosis involves excision of localized focal lesions, known as adenomyomas, to improve uterine structure prior to fertility treatments.

While removing focal lesions can relieve severe symptoms and restore pelvic symmetry, diffuse adenomyosis involving broad areas of muscle tissue often cannot be removed surgically.

When surgical resection is considered, specialists carefully weigh procedure risks against potential fertility benefits before proceeding.

Risks of Adenomyomectomy

A laparoscopic or open adenomyomectomy carries distinct surgical and obstetric risks that require thorough patient evaluation:

Uterine Rupture Risk: Excision leaves myometrial scar tissue, significantly increasing the risk of uterine rupture during future pregnancies.
Prolonged Recovery Timelines: Complete healing of the muscular wall often requires waiting six to twelve months before attempting an embryo transfer.
Disease Recurrence: Because boundaries between healthy muscle and adenomyotic tissue are poorly defined, incomplete removal can lead to rapid disease recurrence.
Scar Tissue Formation: Intrauterine adhesions can develop post-surgery, further compromising the endometrial cavity and implantation capacity.

Prospective parents can consult national surveillance on reproductive technology to evaluate clinical standard guidelines.

What Should You Do After IVF Failure With Adenomyosis?

Experiencing an unsuccessful cycle or repeated implantation failure when carrying adenomyosis requires a structured review of medical parameters rather than repeating identical steps.

Fertility teams evaluate both structural and embryonic factors to determine whether further protocol adjustments offer a realistic path forward.

Repeat Uterine Imaging: High-resolution 3D ultrasound or pelvic MRI assesses changes in junctional zone thickness and tracks disease progression.
Review Embryo Genetics: Preimplantation genetic testing confirms whether failed transfers were linked to chromosomal factors or uterine non-receptivity.
Evaluate Co-Existing Conditions: Diagnostic testing checks for concurrent endometriosis, uterine fibroids, or chronic endometritis that require targeted treatment.
Adjust Transfer Schedules: Specialists review hormone suppression duration and window-of-implantation timing before planning any subsequent transfers.

You can read more about understanding why IVF fails to learn how post-failure evaluations guide clinical adjustments.

Additional Testing After Recurrent IVF Failure

Following repeated implantation loss, fertility specialists run targeted diagnostic tests to evaluate structural, genetic, and tissue-level factors before deciding on another cycle.

Routinely recommended evidence-based assessments include:

High-Resolution Pelvic Imaging: Evaluates junctional zone thickness and structural changes in the myometrium using 3D ultrasound or pelvic MRI.
Preimplantation Genetic Testing (PGT-A): Confirms chromosomal normalcy of blastocysts to isolate uterine factor issues from genetic factors.
Diagnostic Hysteroscopy: Identifies intrauterine adhesions, polyps, or cavity distortion that could physically obstruct implantation.

Selective or emerging testing options include:

Endometrial Receptivity Analysis (ERA): Evaluates the precise window of progesterone administration for timing transfers after recurrent failures.
Uterine Microbiome Assessment: Checks for chronic bacterial inflammation or chronic endometritis in endometrial tissue.
Systemic Immunological Screening: Evaluates systemic autoimmune conditions or clotting factors, though routine testing remains controversial due to limited clinical trial data.

IVF Success Rates with Adenomyosis

Clinical studies show that adenomyosis can reduce embryo implantation rates and live birth outcomes during standard IVF attempts.

Research indicates that live birth rates after embryo transfers in individuals with adenomyosis decrease by approximately 30% to 40% compared to patients without uterine factor complications.

Furthermore, pregnancy outcomes vary substantially depending on whether the disease is focal or diffuse, maternal age, baseline anti-Müllerian hormone (AMH) levels, and embryo quality.

While frozen embryo transfers following down-regulation show improved success rates compared to fresh cycles, severe structural distortion continues to elevate early miscarriage risks.

When Should You Consider Surrogacy?

Gestational surrogacy becomes a clear medical recommendation when severe uterine factor issues prevent a safe pregnancy or disrupt embryo implantation.

Reproductive endocrinologists often suggest transitioning to a gestational carrier during specific clinical decision points:

Multiple Failed Euploid Transfers: Experiencing repeated implantation loss despite transferring chromosomally normal, high-quality blastocysts.
Diffuse Adenomyosis: Extensive involvement across the muscular wall that cannot be surgically corrected or managed with medication.
Severe Uterine Enlargement: Significant physical distortion that compromises endometrial blood flow and increases obstetric complications.
Recurrent Early Miscarriages: Experiencing repeated pregnancy losses directly attributed to uterine non-receptivity or structural insufficiency.
Limited Remaining Embryos: Possessing a small embryo inventory where transferring into a surrogate provides the highest statistical chance of success.

Intended parents can explore surrogacy embryo transfer success rates to evaluate outcome statistics between personal attempts and gestational carrier transfers.

How Surrogacy Can Help After IVF Fails Due to Adenomyosis

Surrogacy separates embryo creation from gestation, allowing intended parents to build a biological family without uterine limitations.

Parents can utilize frozen embryos created from previous IVF cycles or perform a new retrieval to generate additional embryos.

You can review details on the surrogacy medical process overview to understand how clinical care transitions seamlessly to your gestational carrier.

Gestational surrogates undergo medical history reviews, physical exams, and psychological screening based on guidelines established by medical boards.

Candidates must have a history of at least one uncomplicated, full-term pregnancy and pass comprehensive uterine evaluations conducted by your fertility clinic.

How American Surrogacy Helps Protect Your Journey

Transitioning from repeated medical attempts to gestational surrogacy restores momentum to your family-building plans.

American Surrogacy supports intended parents through pre-screened candidate matching, clear timeline management, and financial safeguards designed to protect your investment.

Key program differentiators include:

Efficient Matching Timelines: Broad national recruitment maintains a balanced waiting list, supporting an average match timeline of 1–6 months so you can move forward quickly.
Comprehensive Pre-Screening: Every surrogate completes medical evaluations, background checks, and psychological testing before matching to minimize preventable disruptions.
Financial Protection Safeguards: Our Limited Risk Program offers unlimited rematching without repeating agency match fees if an unexpected medical setback occurs.

You can request free surrogacy information today to see how agency financial protections safeguard your capital.